Proactive Investors USA
Proactive Investors USA
+1 347-449-0879
Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers
December 06, 2022 at 06:40 AM EST
Contact Details
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|